Federal Investigation Launched on Chemical Imports from China
Estimated reading time: 3–5 minutes
In a significant development, the United States International Trade Commission (USITC) has announced the commencement of the final phase of investigations into imports of a chemical from China. This investigation focuses on n-cyclohexylbenzothiazole-2-sulfenamide (CBS), a substance used in industry.
The investigation, cataloged as Nos. 701-TA-797 and 731-TA-1793, seeks to determine if the imports from China harm industries in the U.S. The investigation will also examine if the imports threaten new industries from starting in the U.S. The chemical is thought to be sold for less than its fair value, which can hurt U.S. businesses.
CBS is a powder or granule and may also be found mixed with other substances. It is commonly used in various industrial procedures. This investigation is significant as it assesses whether certain benefits that could harm U.S. industries are being granted to producers of CBS in China.
Those who want more information can contact Jack Brower at the USITC. The public can find updates through the USITC’s internet server.
Individuals and companies interested in participating in the investigation must register by a specific date. The Commission, during this time, will only accept filing through electronic means.
The public hearing related to this investigation will be held on January 14, 2027, at the Commission’s headquarters. Requests to appear at the hearing should be filed by January 8, 2027. Written submissions and comments must follow certain rules and deadlines.
The USITC will provide information before the hearing through written reports. Further information on hearings and investigations can be accessed through the Commission’s website. The outcome of this investigation could significantly impact trade relations and industry practices related to CBS imports.
By order of the Commission, Lisa Barton, Secretary to the Commission, has confirmed all procedures and requirements related to the investigation and hearing process. Details on the procedures are accessible through the Commission’s handbook.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
